ORIGINAL RESEARCH article
Front. Oncol., 02 September 2020
Sec. Cancer Molecular Targets and Therapeutics
Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.01529
RETRACTED: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
- TL
Tongyi Lu †
- LZ
Ligang Zhang †
- WZ
Wenhui Zhu †
- YZ
Yinmei Zhang
- SZ
Simin Zhang
- BW
Binhua Wu
- ND
Ning Deng *
Guangdong Province Engineering Research Center for Antibody Drug and Immunoassay, Department of Biology, Jinan University, Guangzhou, China
Summary
Citation
Lu T, Zhang L, Zhu W, Zhang Y, Zhang S, Wu B and Deng N (2020) RETRACTED: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer. Front. Oncol. 10:1529. doi: 10.3389/fonc.2020.01529
Received
22 January 2020
Accepted
16 July 2020
Published
02 September 2020
Volume
10 - 2020
Edited by
Christina Annunziata, National Cancer Institute (NCI), United States
Reviewed by
Paolo Armando Gagliardi, University of Bern, Switzerland; Xudong Tang, Guangdong Medical University, China
Updates
This article was submitted to Cancer Molecular Targets and Therapeutics, a section of the journal Frontiers in Oncology
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.